Contact Contact usContact us First name * Last name * Message * Email address * All fields are mandatory. The Cell and Gene Therapy Catapult takes your data very seriously. By using this contact form you are consenting to the processing of your personal data as per our privacy policy. Submit Call us +44 (0) 203 728 9500 Address 12th Floor Tower Wing, Guy’s Hospital,Great Maze Pond, London SE1 9RT
Case studies Filter by: CGT Catapult support Clinical operations Commercialisation of research Health economics and market access Industrialisation Manufacturing Regulatory affairs Skills Project application Addressing the industry skills demand Data analytics and process control Digital infrastructure Growing the UK cell and gene therapy ecosystem Outcomes-based reimbursement Pricing and reimbursement strategy Process development Stem cell therapy development T-cell therapy manufacturing Technology for ATMP manufacturing UK clinical trial facilitation Sort by Newest firstOldest first Apply Clear All Sort by Newest firstOldest first view 17 September 2021 Informing strategic decision making in early clinical development: Exploring commercial potential Read more view 04 May 2021 Collaboration within the Catapult Network enables best use of equipment and rapid project set-up Read more view 11 January 2021 Initial work with CGT Catapult has led to Purespring Therapeutics being awarded £45m from Syncona Read more view 10 December 2020 Apprenticeship case study: Andy Chapman, GSK Read more view 29 October 2020 Celebrating the achievements of the Advanced Therapies Apprenticeship Community Read more view 06 August 2020 Advanced therapies apprentice supporting COVID-19 vaccine manufacturing Read more view 27 May 2020 Apprenticeships upskilling pioneering SME Replimune Read more view 16 January 2020 CAR-T cell therapies and the use of outcomes-based reimbursement in the five major European countries Read more view 14 November 2019 A framework for quantifying digital infrastructure upgrade costs in order to address data needs of outcomes-based reimbursement Read more view 22 July 2019 Enabling outcomes-based reimbursement through a universal platform for outcomes data Read more view 11 July 2019 To what extent can the EBMT registry enable outcomes-based reimbursement in oncology in the UK? Read more view 11 July 2019 To what extent can the SACT database enable outcomes-based reimbursement in oncology in England? Read more view 13 March 2019 The appropriateness of the NHR for facilitating performance-based reimbursement in thalassaemia – current state and future perspectives Read more view 18 February 2019 Can the existing data collection infrastructures for patient outcomes enable outcomes-based reimbursement in the UK? Read more view 18 October 2018 Quantifying the cost of implementing an outcomes-based managed entry agreement in acute lymphoblastic leukaemia (ALL) Read more view 01 May 2018 Identifying the price and access potential of a novel ATMP in the United States Read more view 27 March 2018 Enabling a valuable engagement with EMA and HTA bodies as part of the Parallel Consultation procedure Read more view 04 December 2017 Investigating the use of high performance stirred tank bioreactors for development of allogeneic and autologous cell therapies Read more view 04 December 2017 Designing fully automated in-process controls for cell and gene therapy manufacturing Read more view 04 October 2017 Creating a computer model for fluid movement inside a bioreactor Read more view 27 September 2017 Enabling the creation of new products and technologies that meet industry needs Read more view 27 July 2017 Creating an investable opportunity from an academic asset Read more view 18 July 2017 Providing regulatory advice to support the development of automated stem cell production Read more view 21 April 2017 Developing a single cell integration assay to quantify viral DNA in individual cells Read more view 10 March 2017 Creating characterisation and potency assays for an autologous cell therapy product Read more view 18 January 2017 Reimbursement of macrophage therapy liver cirrhosis treatment Read more view 09 January 2017 Developing rapid sterility testing for cell and gene therapies Read more view 23 September 2016 Cell plasticity platform project Read more view 23 September 2016 Working with UK company ReNeuron Read more view 23 September 2016 Creating a new company with the University of Aberdeen Read more view 23 September 2016 Health economics assessment for Athersys inc. Read more view 23 September 2016 Clinical trial of an immuno-oncology treatment with UK Universities Read more view 19 September 2016 Developing benchtop thawing devices with a UK SME Read more view 12 August 2016 Creating EU market access roadmaps for cell and gene therapies Read more
